McKesson (MCK) Given Sell Rating at Credit Suisse Group

Credit Suisse Group reiterated their sell rating on shares of McKesson (NYSE:MCK) in a research report sent to investors on Friday. The brokerage currently has a $130.00 target price on the stock.

A number of other research firms have also issued reports on MCK. Mizuho set a $168.00 target price on McKesson and gave the company a hold rating in a research note on Tuesday, October 24th. ValuEngine upgraded McKesson from a hold rating to a buy rating in a report on Tuesday, October 31st. Zacks Investment Research upgraded McKesson from a hold rating to a buy rating and set a $177.00 price target for the company in a report on Tuesday, December 26th. Needham & Company LLC reiterated a buy rating and issued a $173.00 price target (down from $178.00) on shares of McKesson in a report on Wednesday, November 1st. Finally, Jefferies Group upgraded McKesson from a hold rating to a buy rating and set a $205.00 price target for the company in a report on Wednesday, January 24th. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and ten have given a buy rating to the company. The company has an average rating of Hold and an average price target of $178.97.

Shares of McKesson (NYSE MCK) opened at $152.39 on Friday. McKesson has a 52 week low of $133.82 and a 52 week high of $178.86. The company has a quick ratio of 0.61, a current ratio of 1.07 and a debt-to-equity ratio of 0.63. The stock has a market capitalization of $31,770.00, a P/E ratio of 6.75, a P/E/G ratio of 1.45 and a beta of 1.22.

McKesson (NYSE:MCK) last posted its earnings results on Thursday, February 1st. The company reported $3.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.92 by $0.49. McKesson had a return on equity of 22.98% and a net margin of 2.34%. The firm had revenue of $53.62 billion for the quarter, compared to analyst estimates of $51.98 billion. During the same quarter in the prior year, the company earned $3.04 EPS. McKesson’s revenue was up 7.0% on a year-over-year basis. equities analysts forecast that McKesson will post 12.69 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, April 2nd. Stockholders of record on Thursday, March 1st will be issued a dividend of $0.34 per share. The ex-dividend date is Wednesday, February 28th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.89%. McKesson’s payout ratio is 6.02%.

In other news, Chairman John H. Hammergren sold 65,000 shares of the company’s stock in a transaction on Thursday, December 14th. The stock was sold at an average price of $160.00, for a total transaction of $10,400,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 1.20% of the company’s stock.

Hedge funds have recently added to or reduced their stakes in the company. IHT Wealth Management LLC increased its holdings in shares of McKesson by 64.2% during the 2nd quarter. IHT Wealth Management LLC now owns 486 shares of the company’s stock worth $1,027,000 after buying an additional 190 shares during the last quarter. WFG Advisors LP increased its holdings in McKesson by 5.0% in the 2nd quarter. WFG Advisors LP now owns 859 shares of the company’s stock valued at $141,000 after purchasing an additional 41 shares in the last quarter. CWH Capital Management Inc. acquired a new stake in McKesson in the 2nd quarter valued at $165,000. Wealthcare Advisory Partners LLC acquired a new stake in McKesson in the 3rd quarter valued at $155,000. Finally, Aries Wealth Management acquired a new stake in McKesson in the 4th quarter valued at $218,000. Institutional investors and hedge funds own 88.03% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “McKesson (MCK) Given Sell Rating at Credit Suisse Group” was first published by Stock Observer and is the property of of Stock Observer. If you are accessing this story on another website, it was illegally copied and reposted in violation of United States and international copyright law. The original version of this story can be viewed at https://www.thestockobserver.com/2018/02/06/mckesson-mck-given-sell-rating-at-credit-suisse-group.html.

About McKesson

McKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare.

Analyst Recommendations for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply